T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Peking University Cancer Hospital & Institute
Hoffmann-La Roche
Hebei Medical University Fourth Hospital
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Seagen Inc.
SOLTI Breast Cancer Research Group
Hoffmann-La Roche
Shanghai Jiao Tong University School of Medicine
Shanghai Henlius Biotech
SOLTI Breast Cancer Research Group
QuantumLeap Healthcare Collaborative
Jazz Pharmaceuticals
Genentech, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
National Medical Research Radiological Centre of the Ministry of Health of Russia
AstraZeneca
AstraZeneca
Deraya University
University of Chicago
Merck Sharp & Dohme LLC
Haukeland University Hospital
Alliance Foundation Trials, LLC.
M.D. Anderson Cancer Center
Hoffmann-La Roche
Shanghai Jiao Tong University School of Medicine
Dana-Farber Cancer Institute
R-Pharm
DualityBio Inc.
Eli Lilly and Company